DLL3 Is a Prognostic and Potentially Predictive Biomarker for Immunotherapy Linked to PD/PD-L Axis and NOTCH1 in Pancreatic Cancer.

Biomedicines · 2023 · PMC10604228 · PMID 37893184

Europe PMC DOI

hedged sentence

0.0930

closest p · 1.9× alpha

0.0930

boldest claim

The sentences

a trend towards significancep = 0.093so close (0.05 < p ≤ 0.1)

We also assessed the analysis of DLL3 expression in stroma and found that DLL3 stroma expression exhibited a trend towards significance with PD-L1 (ρ = 0.153; p = 0.093) ( Figure 4 A,C).

also in 2,760 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.